Market closed
Revvity/$RVTY
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Revvity
Revvity provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments. First, its diagnostics segment includes immunodiagnostics, reproductive health, and applied genomics. Second, its discovery and analytical solutions is composed of life science, industrial, environmental, and food applications. Revvity offers products and services ranging from genetic screening and environmental analytical tools to informatics and enterprise software.
Ticker
$RVTY
Sector
Trading on
NYSE
Industry
Life Sciences Tools & Services
Headquarters
Employees
11,500
Website
Revvity Metrics
BasicAdvanced
$13B
Market cap
53.65
P/E ratio
$2.06
EPS
1.06
Beta
$0.28
Dividend rate
0.25%
Dividend yield
Price and volume
Market cap
$13B
Beta
1.06
52-week high
$128.15
52-week low
$97.32
Average daily volume
957K
Dividend rate
$0.28
Financial strength
Current ratio
3.559
Quick ratio
2.663
Long term debt to equity
41.836
Total debt to equity
41.849
Dividend payout ratio (TTM)
13.59%
Interest coverage (TTM)
3.67%
Management effectiveness
Return on assets (TTM)
1.72%
Return on equity (TTM)
3.31%
Valuation
Price to earnings (TTM)
53.647
Price to revenue (TTM)
5.005
Price to book
1.7
Price to tangible book (TTM)
-9.64
Price to free cash flow (TTM)
24.137
Dividend yield (TTM)
0.25%
Forward dividend yield
0.25%
Growth
Revenue change (TTM)
-2.66%
Earnings per share change (TTM)
-65.18%
3-year revenue growth (CAGR)
-13.15%
3-year earnings per share growth (CAGR)
-40.98%
What the Analysts think about Revvity
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Revvity stock.
Revvity Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Revvity Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Revvity News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Market closed
Upcoming events
Jan
17
Revvity
Dividend·Ex-dividend
Feb
7
Revvity
Dividend·Payment
$0.07
Per share
FAQs
What’s the current market cap for Revvity stock?
Revvity (RVTY) has a market cap of $13B as of December 21, 2024.
What is the P/E ratio for Revvity stock?
The price to earnings (P/E) ratio for Revvity (RVTY) stock is 53.65 as of December 21, 2024.
Does Revvity stock pay dividends?
Yes, the Revvity (RVTY) stock pays dividends to shareholders. As of December 21, 2024, the dividend rate is $0.28 and the yield is 0.25%. Revvity has a payout ratio of 13.59% on a trailing twelve-month basis.
When is the next Revvity dividend payment date?
The next Revvity (RVTY) dividend payment is scheduled for February 07, 2025.
What is the beta indicator for Revvity?
Revvity (RVTY) has a beta rating of 1.06. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.